ReviewFrontiers in immunology2021

SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines?

Wilson Lewis Mandala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.